Locomotor Recovery Following Traumatic Brain Injury

NCT04503473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2024-05-02

No results posted yet for this study

Summary

The purpose of this study is to investigate the effectiveness of two different walking training interventions on the recovery of strength, mobility, walking and other measures of health in individuals following traumatic brain injury. During this study, participants will aim to complete up to 15 training sessions over 4-5 weeks of each intervention with at least a 4 week break between interventions. Each training session will last approximately 1 hour, while testing sessions performed at the beginning and end of each intervention will last approximately 3-4 hours. Participation in this research study may last up to 6 months including screening and baseline testing. The possible benefits to participant from participation in this study include increased strength of the participants leg muscles and improved walking ability

Conditions

  • Traumatic Brain Injury (TBI)

Interventions

BEHAVIORAL

High Intensity Stepping Training

The goals will be to maximize stepping activity at high intensities for 40 minutes per 1 hour session, with rest breaks as needed Conventional Therapy: : Participants provided conventional therapy will perform various standardized exercise tasks during 40 minutes of 1 hr sessions

BEHAVIORAL

Conventional Therapy

Participants provided conventional therapy will perform various standardized exercise tasks during 40 minutes of 1 hr sessions

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • George Hornby, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04503473 on ClinicalTrials.gov